Skip to content

MecPain, a New Questionnaire to Assess Chronic Pain Mechanisms.

Validation of a New Clinical Questionnaire for the Evaluation of the Pathophysiological Mechanisms of Chronic Pain MecPain.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05713604
Acronym
MecPain
Enrollment
240
Registered
2023-02-06
Start date
2023-02-02
Completion date
2023-12-01
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Neuropathic pain, Nociplastic pain, Nociceptive pain, Chronic pain mechanisms

Brief summary

Validation of a new clinical questionnaire, called 'MecPain', including 12 questions, aimed at better defining the pathophysiological mechanisms of a chronic pain condition. This questionnaire includes 8 components/sub-components, reflecting various aspects of the 3 main mechanisms of chronic pain: nociceptive, neuropathic, nociplastic. A series of 240 patients with well-characterized chronic pain syndrome (for more than 6 months) of the nociceptive, neuropathic or nociplastic type will be recruited (80 patients per type of pain). The patients will be interviewed by a pain specialist to complete the 12 questions of the questionnaire during a routine visit in a Pain Center (CHU Grenobles Alpes, Grenoble, France or CHU Henri Mondor, Creteil, France). The scoring obtained with the 'MecPain' questionnaire will be compared to the presence of neuropathic pain assessed by two previously validated questionnaires, the 'DN4' and the 'PainDETECT' questionnaires. The expected outcome is a validation of the 'MecPain' questionnaire to provide a better understanding of the pathophysiological mechanisms relating to the presence of a chronic pain syndrome in a given patient.

Detailed description

The main objective of this study is to specify the physiopathological mechanisms of a chronic pain syndrome according to 5 main components (+ 3 sensory sub-components) reflecting various aspects of the 3 main mechanisms of chronic pain: nociceptive, neuropathic, nociplastic. A score will be assigned based on the answers to each of the 12 questions of the 'MecPain' questionnaire for each of the 8 components/sub-components mentioned above. 240 chronic pain patients will be included (in two centers), according to 3 categories: 80 patients with nociceptive pain (mechanical or inflammatory joint or spinal pain), 80 patients with neuropathic pain (painful peripheral neuropathy, neuralgia or radiculalgia, pain related with spinal cord or brain injury), and 80 patients with nociplastic pain (fibromyalgia, glossodynia, temporomandibular joint pain, irritable bowel syndrome, painful bladder syndrome).

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Presence of a chronic pain syndrome (pain for more than 6 months); * well-characterized pain syndrome of the nociceptive, neuropathic or nociplastic type

Exclusion criteria

* Opposition to the use of data obtained in the context of standard clinical follow-up.

Design outcomes

Primary

MeasureTime frameDescription
The scores of the various components of the 'MecPain' questionnaireSix monthsA score will be assigned based on the answers to each of the 12 questions of the 'MecPain' questionnaire

Secondary

MeasureTime frameDescription
The scores of the'DN4' and 'PainDETECT' questionnairesSix monthsScores of the'DN4 ranging from 0 to 10 and scores 'PainDETECT' ranging from 0 to 38

Countries

France

Contacts

Primary ContactHasan HODAJ, MD - PhD
hhodaj@chu-grenoble.fr0476765213
Backup ContactJean-Pascal LEFAUCHEUR, MD - PhD
jean-pascal.lefaucheur@aphp.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026